0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query delveinsight remicade drug insights2014.Your search for "" gave back 957090 results.
Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor. The global Tumor Necrosis Factor Inhibitor Drug...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
A Remicade biosimilar is a biologic medication that is highly similar to Remicade, a brand-name biologic used to treat autoimmune diseases such as...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
A biosimilar of Remicade is a biologic medication that is highly similar to the reference product, Remicade, in terms of safety, efficacy, and...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar...
Catalog:
9Dimen Research
February 2023
Price: USD 3,200.00
Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor. Highlights The global Tumor Necrosis Factor...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar...
Catalog:
9Dimen Research
August 2020
Price: USD 2,850.00
Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor. The global Tumor Necrosis Factor Inhibitor Drug...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The tumor necrosis factor alpha (TNF-a) inhibitors represent one of the major treatment methods for inflammatory diseases. Globally, this drug class...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Rheumatic Disorders Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
February 2023
Price: USD 4,480.00
Highlights The global Tumor Necrosis Factor Inhibitors Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global Tumor Necrosis Factor Inhibitors Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
According to our Publisher latest study, the global Rheumatic Disorders Treatment market size was valued at USD million in 2022 and is forecast to a...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Summary Antibody Drug Conjugates market research report provides the newest industry data and industry future trends, allowing you to identify the...
Catalog:
ICRW
March 2019
Price: USD 2,960.00
